Viewing nowTerbinafine Tablets 125 mg (Terbinafine Hydrochloride)
Terbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

MFDS item code 199902015 · Notified 1999.09.07 · Insurance code 642801440
Treatment of onychomycosis and cutaneous fungal infections (e.g., tinea pedis and tinea corporis), and tinea capitis
This medication is effective for the treatment of tinea pedis, tinea corporis, and tinea cruris caused by dermatophytes in adults, as well as onychomycosis. It is also used for the treatment of tinea capitis in children. It helps improve various skin and nail fungal infections.
Adults Administer 125 mg of terbinafine per dose twice daily or 250 mg per dose once daily. The duration of treatment according to the condition is as follows. 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually administered for 6 weeks~3 months. In cases of infection of the fingernails or relatively small toes, or in younger patients, the treatment period may be shortened to 3 months or less. A treatment period of 3 months is usually sufficient for toenail infections, but some patients may require 6 months or longer. The treatment period may be longer in patients with slow nail growth. Patients with renal impairment For patients with a creatinine clearance of less than 50 mL/min, reduce the daily dose by 1/2.
Administer to children aged 2 years and older. Use is not recommended in children under 2 years of age because there is no experience with its use. Tinea capitis: 4 weeks Tinea capitis occurs mainly in children. To prevent recurrence of the infection, treatment should be administered regularly and for the appropriate prescribed duration. Body weight less than 20 kg (under 5 years): 62.5 mg per dose, once daily. Because experience with use is limited, the decision to administer should be made after considering the benefits and risks of treatment. Body weight 20~40 kg (5~12 years): 125 mg per dose, once daily. Body weight over 40 kg (over 12 years): 250 mg per dose, once daily.
This drug should not be used in patients with chronic liver disease or active liver disease. Before taking this drug, it is important to confirm liver health status and regularly monitor liver function. If liver function test values increase or symptoms such as nausea, decreased appetite, fatigue, vomiting, abdominal pain, or jaundice occur, inform a doctor immediately and discontinue use of the medication. This drug should not be administered to patients with blood disorders, severe renal impairment, lactating women, children under the age of 2, or certain hereditary lactose intolerance patients. It should be used with caution in the elderly, patients with renal impairment, and children weighing less than 20 kg, and if serious skin reactions occur, the medication should be stopped immediately. This drug may cause various side effects including liver damage, blood abnormalities, skin rashes, musculoskeletal pain, gastrointestinal symptoms, and neurological symptoms, so consult a healthcare professional if symptoms occur. Caution should be taken while driving or operating machinery as dizziness may occur. There may be interactions with other medications, so if you are taking any other medications, it is essential to inform your healthcare provider, especially when used with drugs that affect liver metabolism, as dosage adjustments may be necessary. For pregnant women or those who may become pregnant, careful consideration should be given to the use of this medication, and lactating women should discontinue breastfeeding while on this drug. In case of overdose, symptoms such as headache, nausea, abdominal pain, and dizziness can occur, so seek medical attention immediately for proper treatment. Store this drug out of reach of children, away from direct sunlight, and at room temperature.
Liver failure, hepatitis, cholestasis, jaundice, rash, skin itching, fever, nausea, vomiting, loss of appetite, fatigue, elevated γ-GTP, elevated AST/ALT, elevated LDH, elevated ALP, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, petechiae, leukopenia, anemia, rash, itching, photosensitivity reaction, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, blistering dermatitis, psoriatic rash, worsening of psoriasis, hair loss, musculoskeletal response, arthralgia, myalgia, weakness, elevated CPK, increased serum myoglobin, increased urinary myoglobin, hypotension, dyspnea, chest tightness, hives, erythema, facial edema, lymphangiectasia, abdominal distension, decreased appetite, dyspepsia, mild abdominal pain, diarrhea, upper gastrointestinal discomfort, thirst, glossitis, depression, anxiety, headache, loss of taste, taste disturbance, dizziness, drowsiness, sensory disturbances, sensory loss, decreased attention, insomnia, elevated BUN, urinary frequency, visual disturbances, tinnitus, anaphylactic reaction, angioedema, systemic lupus erythematosus, elevated total cholesterol, elevated triglyceride levels, fatigue, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic dysfunction, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reaction, blurred vision, vision impairment, hearing loss, auditory disturbance, vasculitis, permanent anosmia, hyposmia, increased eosinophils with systemic symptoms associated with drug rash, pancreatitis, rhabdomyolysis, influenza-like illness, increased serum creatine phosphokinase
Not everyone experiences these, and they can vary from person to person.
Store this drug in a tightly closed container to prevent air or moisture from entering. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius.
White round tablets
30 tablets/bottle, 140 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTerbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
GP Therapeutics Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Hutex Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Anguk Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Medica Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Daehwa Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.